Author

Emily A. Kolyvas

Observed names: Emily Kolyvas, Kolyvas, Emily, Kolyvas, Emily A

Institution: Cancer Research UK Cambridge Center

Observed institutions: National Institutes of Health, University of Illinois Urbana-Champaign, Medical College of Wisconsin, University of Cambridge, Cancer Research UK, University of Illinois System, Cancer Research UK Cambridge Center, National Cancer Institute, Center for Cancer Research, Cambridge Scholars Publishing

ORCID: 0000-0002-3135-8377

Observed ORCID: 0000-0002-3135-8377

OpenAlex ID: A5000915567

Androgen receptor function and targeted therapeutics across breast cancer subtypes

2022 · Emily A. Kolyvas, Carlos Caldas, et al. · Breast Cancer Research · 79

Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A

2016 · Gilad Kaplan, Fred Lee, et al. · Toxins · 31

Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes

2016 · Emily Kolyvas, Michael Rudloff, et al. · Oncotarget · 26

Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors

2018 · Salma El-Behaedi, Rebekah Landsman, et al. · Toxins · 8

Fitness and transcriptional plasticity of human breast cancer single-cell-derived clones

2025 · Long V. Nguyen, Yaniv Eyal-Lubling, et al. · Cell Reports · 7

The impact of mechanically stimulated muscle-derived stromal cells on aged skeletal muscle

2017 · Heather D. Huntsman, Catarina Rendeiro, et al. · Experimental Gerontology · 7

Abstract 2566: Combination of taxanes with mesothelin-targeted immunotoxin RG7787 induces synergistic killing of pancreatic cancer

2015 · Christine Campo Alewine, Emily Kolyvas, et al. · Cancer Research · 1

Inhibition of AR and DNA-PK for radio-sensitization of AR-driven cancers.

2024 · Emily Kolyvas, Desiree Piscitello, et al. · Journal of Clinical Oncology

Influence of patient awareness and health disparities on early identification of neutropenic sepsis risk.

2024 · Emily Kolyvas, Aislinn O'Farrell, et al. · Journal of Clinical Oncology

Abstract 3964: Mesothelin targeting immunotoxin LMB-100 alters the profile of tumor-secreted proteins

2018 · Salma El-Behaedi, Rebekah Landsman, et al. · Cancer Research

Abstract B37: Mesothelin-targeted immunotoxin RG7787 (LMB-100) preferentially depletes secreted proteins and short-lived intracellular proteins to augment tumor cell killing by taxanes

2016 · Christine Alewine, Rebekah Landsman, et al. · Cancer Research

Abstract C163: Understanding the mechanism for synergistic anti-tumor activity of a meosthelin-targeted immunotoxin and taxanes

2015 · Christine Campo Alewine, Emily Kolyvas, et al. · Molecular Cancer Therapeutics

Harnessing the Potential of Mesenchymal Stem Cells

2014 · Emily Kolyvas · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)

Simultaneous reversal of age‐related declines in muscle health and cognition with transplantation of preconditioned mesenchymal stem cells (1163.2)

2014 · Heather Huntsman, Michael De Lisio, et al. · The FASEB Journal

Works count: 16

Citation count: 159

H-index: 6

I10-index: 3